86 related articles for article (PubMed ID: 8844010)
1. Prenatal screening for trisomy 18.
Reynolds TM; Wierzbicki A
Prenat Diagn; 1996 May; 16(5):475-6; author reply 477-8. PubMed ID: 8844010
[No Abstract] [Full Text] [Related]
2. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE
Prenat Diagn; 2003 Mar; 23(3):243-7. PubMed ID: 12627428
[TBL] [Abstract][Full Text] [Related]
3. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
[No Abstract] [Full Text] [Related]
4. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
Summers AM; Huang T; Wyatt PR
Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
[No Abstract] [Full Text] [Related]
5. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
6. Second trimester two-step trisomy 18 screening using maternal serum markers.
Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
[TBL] [Abstract][Full Text] [Related]
7. False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome.
Baxi L; Brown S; Thaker HM
Fetal Diagn Ther; 2007; 22(4):318-20. PubMed ID: 17361088
[TBL] [Abstract][Full Text] [Related]
8. Prenatal biochemical diagnostics of inborn developmental defects.
Malbohan I; Fialová L; Mikulíková L; Hájek Z
Sb Lek; 1994; 95(4):277-83. PubMed ID: 8867698
[TBL] [Abstract][Full Text] [Related]
9. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
10. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for trisomy 18 in the second trimester.
Canick JA; Palomaki GE; Osathanondh R
Prenat Diagn; 1990 Aug; 10(8):546-8. PubMed ID: 1702538
[No Abstract] [Full Text] [Related]
12. Revised distribution parameters for serum markers for trisomy 18.
Hackshaw AK; Wald NJ
J Med Screen; 2000; 7(4):215. PubMed ID: 11202590
[No Abstract] [Full Text] [Related]
13. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
[TBL] [Abstract][Full Text] [Related]
14. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
Hogge WA; Fraer L; Melegari T
Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
[TBL] [Abstract][Full Text] [Related]
16. Trisomy 9 screened positive for trisomy 18 by maternal serum screening.
Khoury-Collado F; Anderson VM; Haas BR; Fisher AJ; Bombard AT; Weiner Z
Prenat Diagn; 2004 Oct; 24(10):836-8. PubMed ID: 15503288
[No Abstract] [Full Text] [Related]
17. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
18. Biochemical assessment and prediction of gestational well-being.
Martin JN; Cowan BD
Obstet Gynecol Clin North Am; 1990 Mar; 17(1):81-93. PubMed ID: 1694021
[TBL] [Abstract][Full Text] [Related]
19. Sequential pathways of testing after first-trimester screening for trisomy 21.
Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
[TBL] [Abstract][Full Text] [Related]
20. [Prioritization and the "triple"-test in prenatal diagnosis].
Pedersen KM
Ugeskr Laeger; 1999 Dec; 161(50):6901. PubMed ID: 10643374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
